| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/2011 | WO2010144378A3 Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds |
| 04/07/2011 | WO2010139752A3 Stabilised composition comprising at least one adrenergic compound |
| 04/07/2011 | WO2010139751A3 Stabilised composition comprising at least one adrenergic compound |
| 04/07/2011 | WO2010138588A3 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 04/07/2011 | WO2010138010A3 Solvates of decetaxel |
| 04/07/2011 | WO2010135536A9 Methods of modulating uric acid levels |
| 04/07/2011 | WO2010135505A3 Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester |
| 04/07/2011 | WO2010132440A3 Methods for treatment of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers |
| 04/07/2011 | WO2010130900A3 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors |
| 04/07/2011 | WO2010130728A3 Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers |
| 04/07/2011 | WO2010129665A3 Pyrimidine-2,4,6-triones for use in the treatment of amyotrophic lateral sclerosis |
| 04/07/2011 | WO2010129340A3 Novel photosensitizer formulations for oral administration |
| 04/07/2011 | WO2010121352A8 Use of (hexenoyl trans-3)hgrf(l-44)nh2 and simvastatin in combination therapy |
| 04/07/2011 | WO2010116382A3 Stable pharmaceutical compositions of diclofenac |
| 04/07/2011 | WO2010111713A3 N-linked glycan biosynthesis modulators |
| 04/07/2011 | WO2010111436A3 Antiviral compounds and uses thereof |
| 04/07/2011 | WO2010111257A3 Targeted schiff base complexes |
| 04/07/2011 | WO2010111080A3 Ly2140023 for treatment of schizophrenia in patients with variants of htr2a, nrgl, drd2, drd3, comt, grm3 and pkhdl genes |
| 04/07/2011 | WO2010105096A3 Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212) |
| 04/07/2011 | WO2010103544A3 A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants |
| 04/07/2011 | WO2010096564A3 Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits |
| 04/07/2011 | WO2010091354A3 Akt tyrosine 176 phosphorylation cancer biomarker |
| 04/07/2011 | WO2010091277A8 Solid state forms of aliskiren compounds |
| 04/07/2011 | WO2010091104A8 Glucosylceramide synthase inhibitors |
| 04/07/2011 | WO2010090860A3 Methods and compositions for treating bacterial infection |
| 04/07/2011 | WO2010090723A3 Methods of inhibiting fibrogenesis and treating fibrotic disease |
| 04/07/2011 | WO2010088455A3 Cromolyn derivatives and related methods of imaging and treatment |
| 04/07/2011 | WO2010088000A3 Antifibrotic compounds and uses thereof |
| 04/07/2011 | WO2010051926A8 Novel halogen-substituted compounds |
| 04/07/2011 | WO2010041255A3 Liposomal systems comprising sphingomyelin |
| 04/07/2011 | WO2010038091A9 Compositions comrrising amlodipine and bisoprolol |
| 04/07/2011 | WO2010008776A3 Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| 04/07/2011 | WO2010006143A3 Transdermal estrogen device and delivery |
| 04/07/2011 | WO2009149369A3 Acne treatment compositions comprising nanosilver and uses |
| 04/07/2011 | WO2009146910A8 4, 6-diphenylpyrid-2-0nes against cancer |
| 04/07/2011 | WO2009067349A8 Modulation of the immune response |
| 04/07/2011 | US20110083201 Compositions for and methods of grazyme b inhibition |
| 04/07/2011 | US20110082448 Pharmaceutical Compositions |
| 04/07/2011 | US20110082427 Bioresorbable embolization microspheres |
| 04/07/2011 | US20110082407 Combination Therapies for the Treatment of Obesity |
| 04/07/2011 | US20110082305 7-Phenyl-Substituted Tetracycline Compounds |
| 04/07/2011 | US20110082298 Crystal form of quinoline compound and process for its production |
| 04/07/2011 | US20110082218 Treatment and modulation of gene expression and skin aging |
| 04/07/2011 | US20110082216 Benzoyl peroxide composition for treating skin |
| 04/07/2011 | US20110082214 Process for the preparation of a solid dosage form, in particular a tablet, for pharmaceutical use and process for the preparation of a precursor for a solid dosage form, in particular a tablet |
| 04/07/2011 | US20110082213 Novel salts of o-desmethyl-venlafaxine |
| 04/07/2011 | US20110082212 Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 04/07/2011 | US20110082211 Method for treating tinnitus aureum |
| 04/07/2011 | US20110082210 Fatty acid fibrate derivatives and their uses |
| 04/07/2011 | US20110082209 Novel Salts of (4--2-Methylphenyl)Carbonyl]Amino}-3-Methylphenyl)Acetic Acid |
| 04/07/2011 | US20110082208 Therapies for cancer using isotopically substituted lysine |
| 04/07/2011 | US20110082207 Inhibitors of Yeast Filamentous Growth and Method of Their Manufacture |
| 04/07/2011 | US20110082206 Heteroatom containing substituted fatty acids |
| 04/07/2011 | US20110082205 Docosahexaenoic Acid Gel Caps |
| 04/07/2011 | US20110082204 N-alkylcarbonyl-amino acid ester and N-alkylcarbonyl-amino lactone compounds and their use |
| 04/07/2011 | US20110082203 Process to diagnose or treat brain injury |
| 04/07/2011 | US20110082202 Fatty acid acifran derivatives and their uses |
| 04/07/2011 | US20110082201 Use of L-Butylphthalide in the Manufacture of Medicaments for Prevention and Treatment of Cerebral Infarct |
| 04/07/2011 | US20110082200 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
| 04/07/2011 | US20110082199 Use of non-toxic crosslinking reagents to improve fatigue resistance and reduce mechanical degradation of intervertebral disc and other collagenous tissues |
| 04/07/2011 | US20110082198 Theaflavin compositions, production, and methods to control physiological disorders in mammals |
| 04/07/2011 | US20110082197 Method for inhibiting formation and/or activation of osteoclasts using flemingia macrophylla extract or lespedeza flavanone A |
| 04/07/2011 | US20110082196 Theaflavin compositions, related processes and methods of use |
| 04/07/2011 | US20110082195 New use for cannabinoids |
| 04/07/2011 | US20110082194 Synergistic Anticoagulant Composition |
| 04/07/2011 | US20110082193 Taxane derivative containing pharmaceutical composition with improved therapeutic efficacy |
| 04/07/2011 | US20110082192 Lipoic acid acylated salicylate derivatives and their uses |
| 04/07/2011 | US20110082191 Method for treating or preventing radiation damage by in vivo gene therapy |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082189 Use of compounds activating sirt-3 for mimicking exercise |
| 04/07/2011 | US20110082188 Gene expression profiling of inflammatory bowel disease |
| 04/07/2011 | US20110082187 Markers and methods relating to the assessment of alzheimer's disease |
| 04/07/2011 | US20110082186 Compositions for inhibiting gene expression and uses thereof |
| 04/07/2011 | US20110082185 Cancer-testis gene silencing agents and uses thereof |
| 04/07/2011 | US20110082184 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 04/07/2011 | US20110082183 Phenyl pyrrole aminoguanidine derivatives |
| 04/07/2011 | US20110082182 Therapeutic antiviral peptides |
| 04/07/2011 | US20110082181 Compounds as Lysophosphatidic Acid Receptor Antagonists |
| 04/07/2011 | US20110082180 Antimicrobial compounds |
| 04/07/2011 | US20110082179 Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| 04/07/2011 | US20110082178 Methods of treating autoimmune and inflammatory diseases and disorders |
| 04/07/2011 | US20110082177 N'-nitroxyalkylnicotinamides for the treatment of cardiovascular diseases |
| 04/07/2011 | US20110082176 Stilbenes and Chalcones for the Prevention and Treatment of Cardiovascular Diseases |
| 04/07/2011 | US20110082175 Insecticidal aryl pyrrolidines |
| 04/07/2011 | US20110082174 Solid state forms of racemic ilaprazole |
| 04/07/2011 | US20110082173 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 04/07/2011 | US20110082172 Pyrrolidinone carboxamide derivatives |
| 04/07/2011 | US20110082171 Medicaments and Methods for Inhibition of Scarring |
| 04/07/2011 | US20110082170 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof |
| 04/07/2011 | US20110082169 Stable SNS-595 Compositions and Methods of Preparation |
| 04/07/2011 | US20110082168 Compositions for delivering highly water soluble drugs |
| 04/07/2011 | US20110082167 Topical compositions of opioid antagonists and methods for treating skin conditions therewith |
| 04/07/2011 | US20110082166 Novel 4-benzhydryl-tetrahydro-pyridine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/07/2011 | US20110082165 Pyrrolidine gpr40 modulators |
| 04/07/2011 | US20110082164 Polycyclic compounds as lysophosphatidic acid receptor antagonists |
| 04/07/2011 | US20110082163 Novel uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity |
| 04/07/2011 | US20110082161 Powders for reconstitution |
| 04/07/2011 | US20110082159 METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-d]PYRIMIDIN-4-YL)-1H-PYRAZOL-1-YL)-3-CYCLOPENTYLPROPANENITRILE |
| 04/07/2011 | US20110082158 Selective proton coupled folate transporter and folate receptor, and garftase and/or other folate metabolizing enzymes inhibitor compounds and methods of using the same |
| 04/07/2011 | US20110082157 Piperidinylamino-Thieno [2,3-D] Pyrimidine Compounds |